+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 0 - 1Day
All Genders
Healthy Volunteers
ID06789484

Study of Probiotic Supplement Recovery in Healthy Full-term Newborns with Daily Dosing for 4 Weeks

Led by Hvidovre University Hospital · Updated on 2025-04-13

40

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

The BABIES study investigates the recovery and presence of a probiotic strain in healthy newborn infants. This randomized, double-blinded, placebo-controlled trial focuses on full-term newborns from birth to 28 days of life, followed by a 2-week monitoring period. The study aims to understand how the probiotic strain settles in the infants gut by analyzing stool samples. Participants are randomly assigned to receive either a daily probiotic dietary supplement or an identical placebo made of maltodextrin. The intervention lasts for 4 weeks, starting from birth until 28 days of age. The study is conducted at a single center and uses advanced testing methods like strain-specific quantitative Polymerase Chain Reaction qPCR to measure probiotic recovery. Throughout the study, infant stool samples are collected at birth first stool after meconium, 2 weeks, 4 weeks, and 6 weeks to assess the presence of the probiotic strain. Additional measurements include fecal pH, total bifidobacteria levels, and short chain fatty acids. The study also monitors safety and follows up with participants for 2 weeks after the intervention period, with total participation lasting about 6 weeks.

CONDITIONS

Brief Title

Characterization of the Gastrointestinal Microbiota in Newborn Infants

Research Team

S

Sofie Ingdam Halkjær, MSc, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here